Effects of Carvedilol Versus Metoprolol on Endothelial Function and Oxidative Stress in Patients With Type 2 Diabetes Mellitus
Authors:
- A BankABA Bank
- A KellyAKA Kelly
- A ThelenATA Thelen
- D KaiserDKD Kaiser
- J GonzalezcampoyJGJ Gonzalezcampoy
- 1 July 2007
- journal article
- research article
- Published by Oxford University Press (OUP) in American Journal of Hypertension
- Vol. 20 (7) , 777-783
Abstract
Data suggest that carvedilol possesses antioxidant properties that might provide vascular protection. We sought to compare the effects of carvedilol and metoprolol tartrate on endothelial function and oxidative stress in a head-to-head trial. Thirty-four patients with type 2 diabetes mellitus (T2DM) and hypertension were randomized to receive either carvedilol (n = 16) or metoprolol (n = 18) in addition to their current antihypertensive medications for 5 months. The following variables were measured pre- and posttreatment: blood pressure, fasting glucose and insulin, insulin resistance by homeostasis-model assessment, hemoglobin A1c, lipids, C-reactive protein (CRP), 8-isoprostane, asymmetric dimethylarginine, oxidized LDL cholesterol, ultrasound assessment of brachial-artery flow-mediated dilation (FMD), nitroglycerin-induced endothelium-independent dilation (EID), brachial and carotid artery distension, distensibility and compliance, and carotid artery intima-media thickness (cIMT). Both carvedilol and metoprolol treatment resulted in significant and similar decreases in systolic (P < .05) and diastolic (P < .0001) blood pressure. Compared with metoprolol, carvedilol significantly improved FMD (P < .001). No differences between groups were noted for any of the glycemic or lipid variables except for HDL cholesterol, which significantly decreased (P < .05) in the metoprolol group compared with the carvedilol group. No differences were observed between groups for CRP, the markers of oxidative stress, EID, arterial stiffness, or cIMT. Compared with metoprolol, carvedilol significantly improves endothelial function in patients with T2DM. Changes in glycemic control and oxidative stress do not seem to explain the observed improvements in FMD, which suggests that other mechanisms may be involved.Keywords
This publication has 18 references indexed in Scilit:
- Comparison of B-mode and echo tracking methods of assessing flow-mediated dilationUltrasound in Medicine & Biology, 2004
- Metabolic Effects of Carvedilol vs Metoprolol in Patients With Type 2 Diabetes Mellitus and Hypertension: A randomized controlled trial.JAMA, 2004
- Effects of carvedilol on oxidative stress in human endothelial cells and healthy volunteersEuropean Journal of Clinical Pharmacology, 2004
- Impaired brachial artery endothelium-dependent and -independent vasodilation in men with erectile dysfunction and no other clinical cardiovascular diseaseJACC, 2004
- Effect of calcium antagonist or beta blockade treatment on nitric oxide-dependent vasodilation and oxidative stress in essential hypertensive patientsJournal Of Hypertension, 2001
- Carvedilol improves endothelium-dependent dilatation in patients with coronary artery diseaseAmerican Heart Journal, 2000
- Hypertension and Antihypertensive Therapy as Risk Factors for Type 2 Diabetes MellitusNew England Journal of Medicine, 2000
- A comparison of angiotensin-converting enzyme inhibitors, calcium antagonists, beta-blockers and diuretic agents on reactive hyperemia in patients with essential hypertension: a multicenter studyJACC, 2000
- Endogenous Dimethylarginine as an Inhibitor of Nitric Oxide SynthesisJournal of Cardiovascular Pharmacology, 1992
- Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in manDiabetologia, 1985